Lexaria Bioscience Corp. (LEXX)
4.03
-0.46
(-10.24%)
USD |
NASDAQ |
Nov 20, 16:00
4.16
+0.13
(+3.23%)
After-Hours: 20:00
Lexaria Bioscience Total Return Level : 4.03 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 4.03 |
| November 19, 2026 | 4.49 |
| November 18, 2026 | 4.28 |
| November 17, 2026 | 4.18 |
| November 16, 2026 | 4.41 |
| November 13, 2026 | 4.44 |
| November 12, 2026 | 4.18 |
| November 11, 2026 | 4.64 |
| November 10, 2026 | 4.68 |
| November 09, 2026 | 4.54 |
| November 06, 2026 | 4.50 |
| November 05, 2026 | 4.17 |
| November 04, 2026 | 4.07 |
| November 03, 2026 | 4.03 |
| November 02, 2026 | 3.64 |
| October 30, 2026 | 3.49 |
| October 29, 2026 | 3.77 |
| October 28, 2026 | 3.30 |
| October 27, 2026 | 3.22 |
| October 26, 2026 | 2.92 |
| October 23, 2026 | 3.08 |
| October 22, 2026 | 2.99 |
| October 21, 2026 | 2.82 |
| October 20, 2026 | 2.65 |
| October 19, 2026 | 2.60 |
| Date | Value |
|---|---|
| October 16, 2026 | 2.86 |
| October 15, 2026 | 2.99 |
| October 14, 2026 | 2.82 |
| October 13, 2026 | 2.80 |
| October 12, 2026 | 3.27 |
| October 09, 2026 | 3.32 |
| October 08, 2026 | 3.20 |
| October 07, 2026 | 3.46 |
| October 06, 2026 | 3.24 |
| October 05, 2026 | 2.77 |
| October 02, 2026 | 2.88 |
| October 01, 2026 | 3.09 |
| September 30, 2026 | 3.15 |
| September 29, 2026 | 3.13 |
| September 28, 2026 | 3.225 |
| September 25, 2026 | 3.28 |
| September 24, 2026 | 3.37 |
| September 23, 2026 | 3.235 |
| September 22, 2026 | 3.22 |
| September 21, 2026 | 3.425 |
| September 18, 2026 | 3.24 |
| September 17, 2026 | 3.29 |
| September 16, 2026 | 3.095 |
| September 15, 2026 | 3.21 |
| September 14, 2026 | 3.55 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Target Group, Inc. (Canada) | 0.0011 |
| XORTX Therapeutics, Inc. | 0.839 |
| NervGen Pharma Corp. | 1.845 |
| Milestone Pharmaceuticals, Inc. | 0.3711 |
| Appili Therapeutics, Inc. | 0.001 |